Skip to main content
logo
Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.965
-0.025 (-0.84%)
Oct 23, 2026, 1:46 PM EDT - Market open

Lexaria Bioscience Ratios and Metrics

Millions USD. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Market Capitalization
5176281835
Market Cap Growth
-72.32%-72.15%627.66%-51.77%-50.18%13.53%
Enterprise Value
1125351027
Last Close Price
2.9913.2058.6515.7544.4093.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PS Ratio
24.7024.39133.1537.5668.9748.92
PB Ratio
1.046.628.073.172.312.71
P/TBV Ratio
1.096.428.223.292.362.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
EV/Sales Ratio
6.5017.46114.3321.5839.4437.19

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Debt / Equity Ratio
0.020.040.020.060.010.01
Net Debt / Equity Ratio
-0.81-0.71-0.84-0.49-0.80-0.89
Net Debt / EBITDA Ratio
0.480.161.140.210.942.09
Net Debt / FCF Ratio
0.470.181.280.221.242.92
Asset Turnover
0.030.110.080.040.020.09
Inventory Turnover
----2.112.39
Quick Ratio
9.561.566.105.9932.7978.90
Current Ratio
10.602.327.188.0435.9681.18
Return on Equity (ROE)
-162.77%-232.15%-112.36%-130.18%-71.35%-73.16%
Return on Assets (ROA)
-81.30%-111.49%-59.56%-73.59%-39.21%-44.17%
Return on Capital Employed (ROCE)
-170.40%-433.80%-73.30%-228.20%-86.60%-43.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Earnings Yield
-173.45%-69.13%-9.38%-78.45%-41.27%-11.39%
FCF Yield
-155.80%-60.84%-8.09%-69.63%-27.98%-11.28%
Buyback Yield / Dilution
-32.40%-45.34%-87.24%-12.38%-34.02%-58.34%
SEC Filings: 10-K · 10-Q